| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DIS3L | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | CYP4F2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | APLP1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | KCNE2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ADI1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | TVP23B | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | RPL27A | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | CCDC71L | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CYP2C9 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ALDOC | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
